Efficacy and Safety of Ranquilon in Patients With Anxiety Disorders Due to Neurasthenia and Adjustment Disorders

This study is testing whether a medication called Ranquilon can safely and effectively reduce anxiety in adults diagnosed with neurasthenia (a condition causing persistent mental and physical exhaustion) or adjustment disorder (difficulty coping after a stressful life event). **You may be eligible if...** - You are between 18 and 70 years old - You have been diagnosed with neurasthenia or adjustment disorder based on standard criteria - You have moderate anxiety symptoms (as measured by a standard anxiety scale) - You do not have severe suicidal thoughts - You experience significant fatigue **You may NOT be eligible if...** - You have severe anxiety or a formal psychiatric diagnosis beyond the conditions above - You are currently taking psychiatric medications - You have serious physical health problems that could interfere with the study - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.